Literature DB >> 15102795

Bacterial and host factors involved in the major histocompatibility complex class Ib-restricted presentation of Salmonella Hsp 60: novel pathway.

Wei-Feng Lo1, Cory D Dunn, Helena Ong, Eleanor S Metcalf, Mark J Soloski.   

Abstract

Previously, a peptide epitope derived from the Hsp 60 molecule of Salmonella that is presented by the major histocompatibility complex (MHC) class Ib molecule Qa-1 to CD8(+) cytotoxic T cells (CTLs) was described. In the present study we investigated the Salmonella-induced processing and presentation pathway for generating this Qa-1-restricted epitope. Live bacteria and, to a lesser extent, opsonized heat-killed bacteria are able to sensitize target cells for lysis by Salmonella-specific CTL. In contrast, heat-killed bacteria cannot sensitize target cells. Presentation of the Hsp 60 epitope appears independent of bacterial internalization, because cytochalasin D does not affect presentation. Moreover, Salmonella strains defective in the InvA or InvE operon, two critical components of the type III secretion pathway, are as efficient as wild-type Salmonella enterica serovar Typhimurium in sensitizing infected targets to lysis. Collectively, these results suggest the existence of a novel antigen-processing pathway in which exogenous antigens gain access to the cytosolic MHC class I processing machinery. Considering the abundant nature of bacterial Hsp 60 and the upregulation of this protein after Salmonella infection of eukaryotic cells, this mode of antigen presentation may be particularly relevant to understanding the host defense mechanisms against gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102795      PMCID: PMC387849          DOI: 10.1128/IAI.72.5.2843-2849.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Microbial pathogenesis: new niches for salmonella.

Authors:  J H Brumell; A J Perrin; D L Goosney; B B Finlay
Journal:  Curr Biol       Date:  2002-01-08       Impact factor: 10.834

Review 2.  Molecular genetic bases of Salmonella entry into host cells.

Authors:  J E Galán
Journal:  Mol Microbiol       Date:  1996-04       Impact factor: 3.501

Review 3.  A new foreign policy: MHC class I molecules monitor the outside world.

Authors:  K L Rock
Journal:  Immunol Today       Date:  1996-03

Review 4.  Salmonellosis: host immune responses and bacterial virulence determinants.

Authors:  B D Jones; S Falkow
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.

Authors:  M Kovacsovics-Bankowski; K L Rock
Journal:  Science       Date:  1995-01-13       Impact factor: 47.728

6.  Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells.

Authors:  C V Harding; J D Pfeifer
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

7.  Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence.

Authors:  G Szalay; J Hess; S H Kaufmann
Journal:  Eur J Immunol       Date:  1994-07       Impact factor: 5.532

8.  Salmonella typhimurium invasion induces apoptosis in infected macrophages.

Authors:  D M Monack; B Raupach; A E Hromockyj; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Stimulation of protective CD8+ T lymphocytes by vaccination with nonliving bacteria.

Authors:  G Szalay; C H Ladel; S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

10.  Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.

Authors:  C Reis e Sousa; R N Germain
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  7 in total

1.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

2.  rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.

Authors:  Gurpreet Kaur; Chitradevi STS; Charu Nimker; Anju Bansal
Journal:  Cell Mol Immunol       Date:  2014-05-26       Impact factor: 11.530

3.  Heat-shock proteins: inflammatory versus regulatory attributes.

Authors:  Verônica Coelho; Femke Broere; Robert J Binder; Yehuda Shoenfeld; Kamal D Moudgil
Journal:  Cell Stress Chaperones       Date:  2008-02-28       Impact factor: 3.667

4.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

5.  Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein.

Authors:  Yi Xu; Samiksha Wasnik; David J Baylink; Edmundo Carreon Berumen; Xiaolei Tang
Journal:  J Vis Exp       Date:  2017-12-20       Impact factor: 1.355

6.  Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells.

Authors:  Bo Wei; Thomas T Su; Harnisha Dalwadi; Robert P Stephan; Daisuke Fujiwara; Tiffany T Huang; Sarah Brewer; Lindy Chen; Moshe Arditi; James Borneman; David J Rawlings; Jonathan Braun
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

7.  Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.

Authors:  Cristina Latasa; Maite Echeverz; Begoña García; Carmen Gil; Enrique García-Ona; Saioa Burgui; Noelia Casares; Sandra Hervás-Stubbs; Juan José Lasarte; Iñigo Lasa; Cristina Solano
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.